Bank of America Corp DE Has $262.70 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Bank of America Corp DE boosted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating) by 36.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 639,632 shares of the medical instruments supplier’s stock after acquiring an additional 171,554 shares during the quarter. Bank of America Corp DE owned 0.86% of West Pharmaceutical Services worth $262,703,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of WST. Allworth Financial LP increased its stake in shares of West Pharmaceutical Services by 140.0% in the first quarter. Allworth Financial LP now owns 72 shares of the medical instruments supplier’s stock valued at $30,000 after buying an additional 42 shares in the last quarter. Addison Advisors LLC increased its stake in shares of West Pharmaceutical Services by 221.7% in the first quarter. Addison Advisors LLC now owns 74 shares of the medical instruments supplier’s stock valued at $30,000 after buying an additional 51 shares in the last quarter. Artemis Wealth Advisors LLC acquired a new stake in shares of West Pharmaceutical Services in the first quarter valued at $35,000. American National Bank increased its stake in shares of West Pharmaceutical Services by 55.6% in the first quarter. American National Bank now owns 98 shares of the medical instruments supplier’s stock valued at $40,000 after buying an additional 35 shares in the last quarter. Finally, Dividend Assets Capital LLC acquired a new stake in shares of West Pharmaceutical Services in the fourth quarter valued at $51,000. 91.98% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at West Pharmaceutical Services

In related news, insider Silji Abraham sold 5,374 shares of the firm’s stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $343.93, for a total value of $1,848,279.82. Following the transaction, the insider now owns 3,201 shares in the company, valued at $1,100,919.93. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.60% of the stock is owned by company insiders.

West Pharmaceutical Services Stock Performance

Shares of NYSE:WST opened at $269.93 on Tuesday. West Pharmaceutical Services, Inc. has a twelve month low of $261.31 and a twelve month high of $475.00. The firm has a market cap of $19.99 billion, a PE ratio of 29.96, a price-to-earnings-growth ratio of 1.08 and a beta of 1.18. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.41 and a current ratio of 3.13. The business has a fifty day moving average of $312.53 and a 200-day moving average of $330.25.

West Pharmaceutical Services (NYSE:WSTGet Rating) last announced its earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share for the quarter, beating analysts’ consensus estimates of $2.19 by $0.28. The company had revenue of $771.30 million during the quarter, compared to analyst estimates of $754.25 million. West Pharmaceutical Services had a return on equity of 29.08% and a net margin of 23.41%. The firm’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period last year, the company posted $2.46 earnings per share. On average, equities research analysts predict that West Pharmaceutical Services, Inc. will post 9.09 EPS for the current fiscal year.

West Pharmaceutical Services Company Profile

(Get Rating)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

Featured Articles

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.